Diabetes

BOSTON — Continuous glucose monitoring is a well-established therapy for type 2 diabetes on intensive and less intensive therapy, but education, training and infrastructure in the clinic are crucial to its success, according to a speaker.

BOSTON — In this Healio video exclusive, Juan P. Frias, MD, discusses his presentation on newer treatment options for type 2 diabetes at the Cardiometabolic Health Congress.

BOSTON — In this Healio video exclusive, a co-chair of the Cardiometabolic Health Congress discusses various highlights from the first 2.5 days of the meeting.

BOSTON — The concepts of precision diabetes medicine, including individualized therapy, carefully tracked progress and a team approach, can break down therapeutic inertia barriers and help patients achieve remission, according to a speaker.

NASHVILLE, Tenn. — Study results presented at the CHEST Annual Meeting demonstrated higher health care utilization up to 9 months after hospitalization for COVID-19 compared with before hospitalization.

The 2022 Cardiometabolic Health Congress will return in-person to Boston with the latest updates spanning all aspects of cardiometabolic health, including CVD, diabetes, kidney disease, lipid and lifestyle management and obesity.

Insulin rationing is common among patients with diabetes, especially younger adults, those of middle income and those who are uninsured, a recent study published in Annals of Internal Medicine found.

CVD risk factors were associated with mortality in patients hospitalized for COVID-19, but preexisting CVD was not, researchers reported in Circulation: Cardiovascular Quality and Outcomes.

SGLT2 inhibition in older patients with type 2 diabetes was associated with lower risk for incident atrial fibrillation compared with dipeptidyl peptidase IV inhibition or GLP-1 receptor agonist treatment, researchers reported.

A group of representatives from national and international endocrine, nephrology and pediatric societies has proposed changing the name of diabetes insipidus to arginine vasopressin deficiency and arginine vasopressin resistance.